Based on preliminary immuno-screening results, we investigated in detail the expression of Sema3E and its receptors, Plexin-D1 and Neuropilin-1 (Npn1), in human ovarian endometrioid carcinomas. This evidence concerns the gene SEMA3E and ovarian endometrioid carcinoma.